Zhejiang Jolly PharmaceuticalLTD Dividend
Dividend criteria checks 4/6
Zhejiang Jolly PharmaceuticalLTD is a dividend paying company with a current yield of 3.68% that is well covered by earnings.
Key information
3.7%
Dividend yield
65%
Payout ratio
| Industry average yield | 2.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.450 |
| Earnings per share | CN¥0.69 |
| Dividend yield forecast | 3.7% |
Recent dividend updates
Recent updates
It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)
Aug 30
We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease
Jul 29Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%
May 13A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)
May 08There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300181's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300181's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Zhejiang Jolly PharmaceuticalLTD Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300181) | 3.7% |
| Market Bottom 25% (CN) | 0.8% |
| Market Top 25% (CN) | 2.8% |
| Industry Average (Pharmaceuticals) | 2.0% |
| Analyst forecast (300181) (up to 3 years) | 3.7% |
Notable Dividend: 300181's dividend (3.68%) is higher than the bottom 25% of dividend payers in the CN market (0.75%).
High Dividend: 300181's dividend (3.68%) is in the top 25% of dividend payers in the CN market (2.75%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (65.1%), 300181's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (128.8%), 300181's dividend payments are not well covered by cash flows.